SCHEMBL30712899

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	RXFP1	Q9HBX9	1/20	0.63

▸	PTH1R	Q03431	7/20	0.63

▸	RXFP3	Q9NSD7	3/20	0.62

▸	RXFP4	Q8TDU9	2/20	0.62

▸	GLP1R	P43220	5/20	0.61

▸	IL23R	Q5VWK5	3/20	0.59

▸	NPBWR1	P48145	1/20	0.58

▸	ECE1	P42892	1/20	0.58

▸	MUS81	Q96NY9	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31590962	0.92	RXFP1 (0.61)	RXFP1PTH1RRXFP3RXFP4IL23R
SCHEMBL30345176	0.92	RXFP1 (0.61)	RXFP1PTH1RRXFP3RXFP4IL23R
SCHEMBL31514295	0.90	NPBWR1 (0.69)	GLP1RIL23RNPBWR1ECE1MUS81
SCHEMBL30598132	0.90	RXFP1 (0.64)	RXFP1PTH1RGLP1RIL23RNPBWR1
SCHEMBL31461886	0.90	NPBWR1 (0.61)	RXFP3RXFP4IL23RNPBWR1
SCHEMBL30446094	0.90	RXFP1 (0.70)	RXFP1PTH1RGLP1RIL23RECE1
Temporin L SCHEMBL29388128	0.89	PTH1R (0.72)	RXFP1PTH1RGLP1RIL23RECE1
SCHEMBL29973204	0.89	NPBWR1 (0.65)	RXFP1IL23RNPBWR1
SCHEMBL30607407	0.89	GLP1R (0.67)	RXFP1PTH1RRXFP3RXFP4GLP1R
SCHEMBL30220493	0.89	RXFP1 (0.65)	RXFP1PTH1RGLP1RIL23RNPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240003881-A1	SYSTEM AND METHOD FOR RAPID AND SENSITIVE DETECTION OF ANTI-PATHOGEN ANTIBODIES	THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA)	2024-01-04	—	—	US	disclosed